Ezra Faster Scan Study (FasterScan)
Sponsor: Ezra AI, Inc.
A observational or N/A phase clinical study on Cancer and Healthy, this trial is completed. The trial is conducted by Ezra AI, Inc. and has accumulated 10 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Apr 2025 — Present [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Aug 2023 — Jul 2024 [monthly]
Recruiting
-
Dec 2022 — Aug 2023 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Nov 2022 — Dec 2022 [monthly]
Recruiting
-
Oct 2022 — Nov 2022 [monthly]
Recruiting
-
Sep 2022 — Oct 2022 [monthly]
Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2022 — Jul 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ezra AI, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .